Answers are grounded in this paper and cite their sources.
Case report details TTP occurrence in Hodgkin lymphoma treatment with nivolumab, highlighting potential complications.
Abstract Introduction: Nivolumab is an anti-PD-1 monoclonal antibody used in the treatment of relapsed/refractory Hodgkin lymphoma.Case: Herein, we present a rare case of TTP developed following nivolumab treatment in a patient with Hodgkin lymphoma.Conclusion: This case draws attention to hematological toxicities associated with immune checkpoint inhibitors.
No takes yet. Share an insight, caveat, or question.
derya deniz kürekci (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: